Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.
Somerville gene therapy company bluebird bio, once among the highest-profile biotechs in the Boston area, has agreed to be ...
Bluebird Bio (BLUE) announced that it has entered into a definitive agreement to be acquired by funds managed by Carlyle (CG) and SK Capital ...
SK Chemicals announced Tuesday that it will set up a comprehensive plastic recycling solution center at its plant in Ulsan.
Facing Trump, AI disruption, South Koreas top conglomerates shed billions Restructuring clears the way for aggressive M&A in ...
SK chemicals, the first company in the world to successfully mass-produce chemically recycled materials, has embarked on ...
Lotte Group, South Korea’s sixth-largest conglomerate, is speeding up its business streamlining efforts amid mounting debts ...
SK Biopharma recruits GSK experts to boost US research and development SK Biopharma enhances its US operations by enlisting ...